Phase III

Explore academic connections and research related to this keyword

305
Views
25
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study
Yoo DH;Hrycaj P;Miranda P;Ramiterre E;Piotrowski M;Shevchuk S;Kovalenko V;Prodanovic N;Abello-Banfi...
2013 annals of the rheumatic diseases 459 views
2
Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study
Chiappella A;Martelli M;Angelucci E;Brusamolino E;Evangelista A;Carella AM;Stelitano C;Rossi G;Balza...
2017 the lancet oncology 403 views
3
Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration
Keane PA;Patel PJ;Ouyang Y;Chen FK;Ikeji F;Walsh AC;Tufail A;Sadda SR;;
2010 investigative ophthalmology & visual science 453 views
4
Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial
Suh CH;Yoo DH;Berrocal Kasay A;Chalouhi El-Khouri E;Cons Molina FF;Shesternya P;Miranda P;Medina-Rod...
2019 biodrugs : clinical immunotherapeutics, biopharmac... 529 views
5
Telaprevir for previously untreated chronic hepatitis C virus infection
Jacobson IM;McHutchison JG;Dusheiko G;Di Bisceglie AM;Reddy KR;Bzowej NH;Marcellin P;Muir AJ;Ferenci...
2011 The New England journal of medicine 524 views
6
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
Arbeit RD;Maki D;Tally FP;Campanaro E;Eisenstein BI; ;;
2004 Clinical infectious diseases : an official publica... 415 views
7
Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh
Feller AJ;Zaman K;Lewis KD;Hossain I;Yunus M;Sack DA;;
2012 Vaccine 380 views
8
Vedolizumab as induction and maintenance therapy for ulcerative colitis
Feagan BG;Rutgeerts P;Sands BE;Hanauer S;Colombel JF;Sandborn WJ;Van Assche G;Axler J;Kim HJ;Danese...
2013 The New England journal of medicine 437 views
9
Boceprevir for untreated chronic HCV genotype 1 infection
Poordad F;McCone J;Bacon BR;Bruno S;Manns MP;Sulkowski MS;Jacobson IM;Reddy KR;Goodman ZD;Boparai N;...
2011 The New England journal of medicine 389 views
10
Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care
Vekemans J;Marsh K;Greenwood B;Leach A;Kabore W;Soulanoudjingar S;Asante KP;Ansong D;Evans J;Sacarla...
2011 malaria journal 304 views
11
Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine
Breiman RF;Zaman K;Armah G;Sow SO;Anh DD;Victor JC;Hille D;Ciarlet M;Neuzil KM;;
2012 Vaccine 380 views
12
Sampling at community level by using satellite imagery and geographical analysis
Escamilla V;Emch M;Dandalo L;Miller WC;Martinson F;Hoffman I;;
2014 bulletin of the world health organization 248 views
13
A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)
Rowe JM;Andersen JW;Mazza JJ;Bennett JM;Paietta E;Hayes FA;Oette D;Cassileth PA;Stadtmauer EA;Wierni...
1995 Blood 340 views
14
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
Jackson LA;Gurtman A;Rice K;Pauksens K;Greenberg RN;Jones TR;Scott DA;Emini EA;Gruber WC;Schmoele-Th...
2013 Vaccine 277 views
15
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection
Afdhal N;Zeuzem S;Kwo P;Chojkier M;Gitlin N;Puoti M;Romero-Gomez M;Zarski JP;Agarwal K;Buggisch P;Fo...
2014 The New England journal of medicine 244 views
16
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials
Jacobson IM;Lawitz E;Gane EJ;Willems BE;Ruane PJ;Nahass RG;Borgia SM;Shafran SD;Workowski KA;Pearlma...
2017 gastroenterology 263 views
17
Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial
Wyles D;Poordad F;Wang S;Alric L;Felizarta F;Kwo PY;Maliakkal B;Agarwal K;Hassanein T;Weilert F;Lee...
2018 Hepatology (Baltimore, Md.) 275 views
18
Continuous lenalidomide treatment for newly diagnosed multiple myeloma
Palumbo A;Hajek R;Delforge M;Kropff M;Petrucci MT;Catalano J;Gisslinger H;Wiktor-Jędrzejczak W;Zodel...
2012 The New England journal of medicine 344 views
19
Fidaxomicin versus vancomycin for Clostridium difficile infection
Louie TJ;Miller MA;Mullane KM;Weiss K;Lentnek A;Golan Y;Gorbach S;Sears P;Shue YK; ;;
2011 The New England journal of medicine 269 views
20
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis
Asselah T;Kowdley KV;Zadeikis N;Wang S;Hassanein T;Horsmans Y;Colombo M;Calinas F;Aguilar H;de Ledin...
2018 clinical gastroenterology and hepatology : the off... 298 views

Related Journals

No Journals Found

No journals are currently associated with this keyword.

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't adult female male adolescent aged middle aged young adult Clinical Trial